Cannabis industry expected to hit $41 Billion by 2025

Cannabis industry expected to hit $41 Billion...

Up next

Waka Flocka Flame introducing igethi

www.igethi.com  A unique beverage experience is now available! Good vibes at the Champs tradeshow, debuting the new **Drink 2 Joints** collab with Good Vibe Tribe, Sublime & The I heart radio crew for cannabis talk 101. Stay tuned...more Good vibes coming your way just in time fo ...  Show more

Freeway Ricky Ross, Former Drug Kingpin, Author, & CEO of LA Kingpin™

Join us as we dive deep into Freeway Rick’s life journey, exploring his highs, lows, & relationship with cannabis today! From street hustler to motivational speaker & mentor, his story is a beacon of hope that reminds us all that transformation is within reach, no matter where we ...  Show more

Recommended Episodes

GW's Gover on Cannabis-Derived Drug for Rare Epilepsy (Audio)
The Tape

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Justin Gover, CEO of GW Pharmaceuticals, on the drug pipeline for the UK- based company which has been developing drug treatments derived from cannabis for decades. Learn more about your ad-choices at https://www ...  Show more

The Cannabis Trade: An Industry Set to Take Off (w/ Jason Wild and Tony Greer)
Real Vision: Finance & Investing

The Interview. Jason Wild, founder of JW Asset Management, sits down with Tony Greer, founder of TG Macro, to discuss his career journey from pharmacist to investor with a firm that oversees $1 billion through a mix of investments in pharmaceuticals and cannabis producers. Wild’s ...  Show more

Go Green & Get Money: Opportunities in the Cannabis Industry with Dr. Lance McCarthy
Straight Shot, No Chaser with Tezlyn Figaro

Tezlyn chats with Dr. Lance McCarthy about how Black Americans can benefit from the cannabis industry beyond owning a dispensary and how the industry is changing the criminal justice system.   Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio. ...  Show more

Pharma raises its bet on biotech
Behind the Money

In the past month pharmaceutical companies have spent almost $100bn acquiring biotech companies. The FT's Sarah Neville explains why big pharma is raising its bet on the drug pipelines owned by biotechs, and why analysts expect more consolidation in 2019. 


Read ...

  Show more